JAZZ PHARMACEUTICALS PLCJAZZ PHARMACEUTICALS PLCJAZZ PHARMACEUTICALS PLC

JAZZ PHARMACEUTICALS PLC

No trades
See on Supercharts

Price target

3,669.530.000.00%
The 16 analysts offering 1 year price forecasts for JAZZ/N have a max estimate of — and a min estimate of —.

Analyst rating

Based on 19 analysts giving stock ratings to JAZZ/N in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


JAZZ/N EPS for the last quarter is 34.42 MXN despite the estimation of 95.42 MXN. In the next quarter EPS is expected to reach −124.94 MXN. Track more of JAZZ PHARMACEUTICALS PLC financials and stay on top of what is up with the company.
In the next quarter JAZZ PHARMACEUTICALS PLC revenue is expected to reach ‪20.52 B‬ MXN. Check out JAZZ PHARMACEUTICALS PLC revenue and earnings and make informed decisions.
According to analysts, JAZZ/N price target is 3,669.53 MXN with a max estimate of 4,433.31 MXN and a min estimate of 2,833.46 MXN. Check if this forecast comes true in a year, meanwhile watch JAZZ PHARMACEUTICALS PLC stock price chart and keep track of the current situation with JAZZ/N news and stock market news.
We've gathered opinions of 19 analysts rating JAZZ/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.